Kedrion Biopharma
Gilbert P. is an accomplished professional in the field of quality systems and compliance, currently serving as Quality Systems & Compliance Manager at Kedrion Biopharma since November 2016, and previously held roles including Quality Assurance Supervisor and QA Specialist. Prior experience includes a significant tenure at Pfizer (formerly Wyeth) from April 2007 to October 2016 as a Sr. Compliance Associate/Sr. Lead Investigator, where over 90% of investigations were closed within due dates, contributing to over 96% product schedule adherence. Earlier experience includes a position as Senior Scientist at Roche Molecular Systems from January 2002 to April 2007, where leadership of a team of scientists and management of a $16 million inventory of raw materials were key responsibilities. Gilbert P. holds a Bachelor of Science in Biology from Saint Peter's University, earned between 1996 and 2000.
This person is not in any teams
This person is not in any offices
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.